PSTV Stock Analysis: Buy, Sell, or Hold?
PSTV - PLUS THERAPEUTICS, Inc. Common Stock
$0.23
-0.02 (-6.94%)
▼
5d:
-15.86%
30d:
-58.05%
90d:
-57.76%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When PSTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called PSTV this week
80% bullish • 1 bearish
80% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PSTV is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PSTV is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PSTV is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.57.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $0.22, while resistance sits at $0.32. Short-term momentum is weak, with the stock down 6.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.38 (+2694.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PSTV is in a strong uptrend. Immediate support is located at $0.22, while resistance sits at $0.32. Short-term momentum is weak, with the stock down 6.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.38 (+2694.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.28 -
$0.57
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-6.9%)
- BULLISH: Trading 2694.8% below Wall St target ($6.38)
- WARNING: Recommendation downgraded due to -15.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.28 -
$0.57
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.32
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.82
Wall Street Target
$6.38
(+2694.8%)
Revenue Growth (YoY)
-4.1%
Last updated: February 01, 2026 9:37 PM ET
Data refreshes hourly during market hours. Next update: 10:37 PM
Data refreshes hourly during market hours. Next update: 10:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PSTV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Robert P Lenk
BUY
110000 shares
2025-08-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
